Cardlytics Stock Today

CDLX Stock  USD 2.35  0.00  0.00%   

Performance

Very Weak

 
Weak
 
Strong

Odds Of Distress

Quite High

 
High
 
Low
Cardlytics is trading at 2.35 as of the 17th of March 2025; that is No Change since the beginning of the trading day. The stock's open price was 2.345. Cardlytics has more than 66 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 17th of December 2024 and ending today, the 17th of March 2025. Click here to learn more.
Business Domain
Media & Entertainment
IPO Date
9th of February 2018
Category
Communication Services
Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. The company was incorporated in 2008 and is headquartered in Atlanta, Georgia. Cardlytics operates under Advertising Agencies classification in the United States and is traded on NASDAQ Exchange. The company has 52.09 M outstanding shares of which 8.33 M shares are currently shorted by private and institutional investors with about 10.59 trading days to cover. More on Cardlytics

Moving together with Cardlytics Stock

  0.89GCI GannettPairCorr
  0.74QNST QuinStreetPairCorr
  0.79CNET ZW Data ActionPairCorr

Moving against Cardlytics Stock

  0.69T ATT Inc Earnings Call This WeekPairCorr
  0.66KT KT CorporationPairCorr
  0.66VZ Verizon Communications Sell-off TrendPairCorr
  0.65YY YY Inc Class Earnings Call TodayPairCorr
  0.64ZH Zhihu Inc ADR Earnings Call This WeekPairCorr
  0.58TU Telus Corp Sell-off TrendPairCorr

Cardlytics Stock Highlights

ESG Sustainability
Environmental
Governance
Social
CEO DirectorAmit Gupta
Business ConcentrationAdvertising, Media & Entertainment, Communication Services, Nasdaq Benchmark Consumer, NASDAQ Composite, Communication Services, Media, Advertising Agencies, Communication Services (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.860.7087
Fairly Up
Slightly volatile
Gross Profit Margin0.30.38
Significantly Down
Slightly volatile
Total Current Liabilities138.3 M149 M
Significantly Down
Slightly volatile
Non Current Liabilities Total205 M173.8 M
Fairly Up
Pretty Stable
Total Assets439.2 M392.7 M
Moderately Up
Slightly volatile
Total Current Assets212 M178 M
Fairly Up
Slightly volatile
Debt Levels
Cardlytics can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Cardlytics' financial leverage. It provides some insight into what part of Cardlytics' total assets is financed by creditors.
Liquidity
Cardlytics currently holds 221.65 M in liabilities with Debt to Equity (D/E) ratio of 0.42, which is about average as compared to similar companies. Cardlytics has a current ratio of 0.88, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Cardlytics' use of debt, we should always consider it together with its cash and equity.

Depreciation

18.22 Million
Cardlytics (CDLX) is traded on NASDAQ Exchange in USA. It is located in 675 Ponce de Leon Avenue NE, Atlanta, GA, United States, 30308 and employs 454 people. Cardlytics is listed under Advertising category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 128.65 M. Cardlytics conducts business under Media sector and is part of Communication Services industry. The entity has 52.09 M outstanding shares of which 8.33 M shares are currently shorted by private and institutional investors with about 10.59 trading days to cover. Cardlytics currently holds about 157.04 M in cash with (8.82 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.77, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Cardlytics Probability Of Bankruptcy
Ownership Allocation
Cardlytics holds a total of 52.09 Million outstanding shares. Over half of Cardlytics' outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Cardlytics Ownership Details

Cardlytics Stock Institutional Holders

InstituionRecorded OnShares
Dimensional Fund Advisors, Inc.2024-12-31
498.1 K
Citigroup Inc2024-12-31
477.3 K
Ubs O'connor Llc2024-12-31
450 K
Renaissance Technologies Corp2024-12-31
403.4 K
Charles Schwab Investment Management Inc2024-12-31
402.6 K
Morgan Stanley - Brokerage Accounts2024-12-31
389.8 K
Northern Trust Corp2024-12-31
373.8 K
Landscape Capital Management,llc2024-12-31
339.2 K
Pb Investment Partners, L.p.2024-12-31
338.2 K
Blackrock Inc2024-12-31
3.2 M
Vanguard Group Inc2024-12-31
2.7 M
View Cardlytics Diagnostics

Cardlytics Historical Income Statement

At this time, Cardlytics' Gross Profit is fairly stable compared to the past year. Operating Income is likely to rise to about 125.5 M in 2025, whereas Interest Income is likely to drop slightly above 3.4 M in 2025. View More Fundamentals

Cardlytics Stock Against Markets

Cardlytics Corporate Management

Additional Tools for Cardlytics Stock Analysis

When running Cardlytics' price analysis, check to measure Cardlytics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardlytics is operating at the current time. Most of Cardlytics' value examination focuses on studying past and present price action to predict the probability of Cardlytics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardlytics' price. Additionally, you may evaluate how the addition of Cardlytics to your portfolios can decrease your overall portfolio volatility.